Market Overview:
The global viral vectors market is expected to grow at a CAGR of 10.8% from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of chronic diseases, rising demand for gene therapy and growing investments in the field of gene therapy. Based on type, the retroviral vectors segment is expected to account for the largest share of the global viral vectors market in 2018. This segment is also projected to grow at a higher CAGR during the forecast period. The large share and high growth rate of this segment can be attributed to factors such as rising incidence of cancer and increasing demand for targeted therapies. Based on application, cancers are estimated to account for the largest share of the global viral vectors market in 2018. This application segment is also projected grow at a higher CAGR duringthe forecast period owingto increase incidencesof cancer worldwideand growing demand fortargeted therapies .
Product Definition:
A viral vector is a virus that has been genetically modified to carry a foreign gene into a host cell. Viral vectors are important tools for gene therapy, as they can transfer genes into cells without causing disease.
Retroviral Vectors:
Retroviral vectors are used to deliver genes into cells. They are also used as a tool for gene therapy and research purposes. The most commonly used retrovirus is the HIV-1 which contains the human immunodeficiency virus's (HIV) genome in it's viral core. Retroviruses can integrate their genomes into the host DNA of various types of organisms including humans, mice, etc., thereby leading to viral infection and disease transmission.
Lentiviral Vectors:
Lentiviral vectors are a class of viral vectors that contain the gene for the Lentivector (LSL) protein. The LSL protein is used for transporting small payloads into cells. They are most commonly used in gene therapy as they can deliver nucleic acids to specific cells with high efficiency and specificity.
Application Insights:
On the basis of application, the global viral vectors market is segmented into oncology, infectious diseases, genetic disorders and others. The infectious diseases segment held the largest share in 2017 owing to high usage of these vectors for treatment of various types of viral infections. Furthermore, growing incidence of chronic conditions such as cancer across the globe will boost demand for efficient treatment solutions leading to increased adoption of gene therapy and other viral vector-based therapies.
The genetic disorders segment is expected to witness lucrative growth over the forecast period due to rising incidences associated with rare diseases caused by mutations in several genes including BRAC1 and 2, CEP63, SMARCD5 and 6 among others which can be cured only by targeted delivery using adenoviral or lentiviral VEVs.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of research organizations, universities, and institutes engaged in R&D activities related to viral vectors. The U.S.-based companies are at the forefront in developing and commercializing these products globally. For instance, according to data published on WebofKnowledge Unleashed by Packaged Facts LLC., United States-based company Intuitive Surgical received FDA approval for its product VirGen 10/11 system that is used for gene therapy procedures involving adenovirus vector technology (previously known as Savvy).
Asia Pacific is expected to register significant growth over the forecast period owing to increasing awareness about advanced treatment options among patients coupled with government initiatives favoring such therapies over conventional ones.
Growth Factors:
- Increasing demand for gene therapy and regenerative medicine
- Rising prevalence of chronic diseases
- Technological advancements in viral vector production and delivery methods
- Growing investment in life sciences sector
- Increasing public-private partnerships for viral vector development
Scope Of The Report
Report Attributes
Report Details
Report Title
Viral Vectors Market Research Report
By Type
Retroviral Vectors, Lentiviral Vectors, Adenoviral Vectors, Herpes Simplex Virus Vectors, Chimeric Viral Vectors, Others
By Application
Cancers, Inherited Disorders, Viral Infections, Others
By Companies
BioReliance, Cobra Biologics, Oxford BioMedica, UniQure, FinVector, MolMed, MassBiologics, Richter-Helm, FUJIFILM Diosynth Biotechnologies, Lonza, Aldevron, Eurogentec, Cell and Gene Therapy Catapult, Biovian, Brammer Bio, VGXI, PlasmidFactory
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
248
Number of Tables & Figures
174
Customization Available
Yes, the report can be customized as per your need.
Global Viral Vectors Market Report Segments:
The global Viral Vectors market is segmented on the basis of:
Types
Retroviral Vectors, Lentiviral Vectors, Adenoviral Vectors, Herpes Simplex Virus Vectors, Chimeric Viral Vectors, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Cancers, Inherited Disorders, Viral Infections, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- BioReliance
- Cobra Biologics
- Oxford BioMedica
- UniQure
- FinVector
- MolMed
- MassBiologics
- Richter-Helm
- FUJIFILM Diosynth Biotechnologies
- Lonza
- Aldevron
- Eurogentec
- Cell and Gene Therapy Catapult
- Biovian
- Brammer Bio
- VGXI
- PlasmidFactory
Highlights of The Viral Vectors Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Retroviral Vectors
- Lentiviral Vectors
- Adenoviral Vectors
- Herpes Simplex Virus Vectors
- Chimeric Viral Vectors
- Others
- By Application:
- Cancers
- Inherited Disorders
- Viral Infections
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Viral Vectors Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Viral vectors are a type of vector that can transfer genetic material from one organism to another. Viral vectors are often used to transfer genes into cells in order to create new products or treatments.
Some of the major companies in the viral vectors market are BioReliance, Cobra Biologics, Oxford BioMedica, UniQure, FinVector, MolMed, MassBiologics, Richter-Helm, FUJIFILM Diosynth Biotechnologies, Lonza, Aldevron, Eurogentec, Cell and Gene Therapy Catapult, Biovian, Brammer Bio, VGXI, PlasmidFactory.
The viral vectors market is expected to grow at a compound annual growth rate of 10.8%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Viral Vectors Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Viral Vectors Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Viral Vectors Market - Supply Chain
4.5. Global Viral Vectors Market Forecast
4.5.1. Viral Vectors Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Viral Vectors Market Size (000 Units) and Y-o-Y Growth
4.5.3. Viral Vectors Market Absolute $ Opportunity
5. Global Viral Vectors Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Viral Vectors Market Size and Volume Forecast by Type
5.3.1. Retroviral Vectors
5.3.2. Lentiviral Vectors
5.3.3. Adenoviral Vectors
5.3.4. Herpes Simplex Virus Vectors
5.3.5. Chimeric Viral Vectors
5.3.6. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Viral Vectors Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Viral Vectors Market Size and Volume Forecast by Application
6.3.1. Cancers
6.3.2. Inherited Disorders
6.3.3. Viral Infections
6.3.4. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Viral Vectors Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Viral Vectors Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Viral Vectors Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Viral Vectors Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Viral Vectors Demand Share Forecast, 2019-2026
9. North America Viral Vectors Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Viral Vectors Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Viral Vectors Market Size and Volume Forecast by Application
9.4.1. Cancers
9.4.2. Inherited Disorders
9.4.3. Viral Infections
9.4.4. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Viral Vectors Market Size and Volume Forecast by Type
9.7.1. Retroviral Vectors
9.7.2. Lentiviral Vectors
9.7.3. Adenoviral Vectors
9.7.4. Herpes Simplex Virus Vectors
9.7.5. Chimeric Viral Vectors
9.7.6. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Viral Vectors Demand Share Forecast, 2019-2026
10. Latin America Viral Vectors Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Viral Vectors Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Viral Vectors Market Size and Volume Forecast by Application
10.4.1. Cancers
10.4.2. Inherited Disorders
10.4.3. Viral Infections
10.4.4. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Viral Vectors Market Size and Volume Forecast by Type
10.7.1. Retroviral Vectors
10.7.2. Lentiviral Vectors
10.7.3. Adenoviral Vectors
10.7.4. Herpes Simplex Virus Vectors
10.7.5. Chimeric Viral Vectors
10.7.6. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Viral Vectors Demand Share Forecast, 2019-2026
11. Europe Viral Vectors Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Viral Vectors Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Viral Vectors Market Size and Volume Forecast by Application
11.4.1. Cancers
11.4.2. Inherited Disorders
11.4.3. Viral Infections
11.4.4. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Viral Vectors Market Size and Volume Forecast by Type
11.7.1. Retroviral Vectors
11.7.2. Lentiviral Vectors
11.7.3. Adenoviral Vectors
11.7.4. Herpes Simplex Virus Vectors
11.7.5. Chimeric Viral Vectors
11.7.6. Others
1.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Viral Vectors Demand Share, 2019-2026
12. Asia Pacific Viral Vectors Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Viral Vectors Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Viral Vectors Market Size and Volume Forecast by Application
12.4.1. Cancers
12.4.2. Inherited Disorders
12.4.3. Viral Infections
12.4.4. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Viral Vectors Market Size and Volume Forecast by Type
12.7.1. Retroviral Vectors
12.7.2. Lentiviral Vectors
12.7.3. Adenoviral Vectors
12.7.4. Herpes Simplex Virus Vectors
12.7.5. Chimeric Viral Vectors
12.7.6. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Viral Vectors Demand Share, 2019-2026
13. Middle East & Africa Viral Vectors Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Viral Vectors Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Viral Vectors Market Size and Volume Forecast by Application
13.4.1. Cancers
13.4.2. Inherited Disorders
13.4.3. Viral Infections
13.4.4. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Viral Vectors Market Size and Volume Forecast by Type
13.7.1. Retroviral Vectors
13.7.2. Lentiviral Vectors
13.7.3. Adenoviral Vectors
13.7.4. Herpes Simplex Virus Vectors
13.7.5. Chimeric Viral Vectors
13.7.6. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Viral Vectors Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Viral Vectors Market: Market Share Analysis
14.2. Viral Vectors Distributors and Customers
14.3. Viral Vectors Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. BioReliance
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Cobra Biologics
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Oxford BioMedica
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. UniQure
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. FinVector
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. MolMed
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. MassBiologics
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Richter-Helm
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. FUJIFILM Diosynth Biotechnologies
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Lonza
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Aldevron
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Eurogentec
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Cell and Gene Therapy Catapult
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Biovian
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. Brammer Bio
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. VGXI
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. PlasmidFactory
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
